NIR‐II Type I Photosensitizer for Efficient Cancer Therapy Through Synergistic Ferroptosis/Pyroptosis Induction and Mitophagy Inhibition
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202501346 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Jiabao Zhuang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Applied Surface and Colloid Chemistry of Ministry of Education, Key Laboratory of Macromolecular Science of Shaanxi Province, Schoo…. Hauptthemen laut MEDLINE: Ferroptosis, Mitophagy, Photosensitizing Agents, Pyroptosis. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The advancement of tumor‐targeted phototheranostics requires photosensitizers (PSs) exhibiting multimodal intervention capacities, such as mitophagy regulation and programmed cell death activation. However, the rational design of such PSs remains a significant challenge in precision oncology. In this study, a mitochondria‐targeted near‐infrared II (NIR‐II) emissive PS (MTC) is reported, which synergistically induces ferroptosis and pyroptosis while inhibiting mitophagy for precise tumor ablation. Through strategic π ‐conjugation extension, MTC achieves NIR‐I absorption and NIR‐II emission properties. Its optimized radiative and non‐radiative decay facilitates type I reactive oxygen species (ROS) generation and high photothermal conversion. The lipocationic nature of MTC ensures its selective accumulation in the mitochondria of cancer cells. Upon laser irradiation, MTC‐mediated phototherapy triggers lipid peroxidation and mitochondrial membrane disruption, inducing synergistic ferroptosis and pyroptosis. Meanwhile, mitochondrial damage initiates mitophagy but subsequently blocks mitophagic flux at the autophagosome stage, amplifying ferroptosis and pyroptosis. These collaborative actions elicit immunogenic cell death, stimulating a robust immune response. MTC nanoparticles (NPs) enable high‐resolution NIR‐II fluorescence imaging of murine vasculature and dynamic respiratory tracking. Notably, MTC NPs demonstrate precise tumor‐specific accumulation, enabling highly effective antitumor phototherapy. This mitochondria‐targeted theranostic paradigm advances precision oncology by interlinking photodamage with programmed cell death networks and mitophagy regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Applied Surface and Colloid Chemistry of Ministry of Education, Key Laboratory of Macromolecular Science of Shaanxi Province, School of Chemistry & Chemical Engineering, Shaanxi Normal University, Xi'a…
ORCID-Profile: Na Zhao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhuang, J., Song, S., Yang, L., Pan, Q., He, Y., Huo, L., Li, N., & Zhao, N. (2025). NIR‐II Type I Photosensitizer for Efficient Cancer Therapy Through Synergistic Ferroptosis/Pyroptosis Induction and Mitophagy Inhibition. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202501346
Vancouver
Zhuang J, Song S, Yang L, Pan Q, He Y, Huo L, et al. NIR‐II Type I Photosensitizer for Efficient Cancer Therapy Through Synergistic Ferroptosis/Pyroptosis Induction and Mitophagy Inhibition. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202501346
BibTeX
@article{Zhuang2025,
author = {Zhuang, Jiabao and Song, Shaoyang and Yang, Lijin and Pan, Quan and He, Yun and Huo, Lantian and Li, Nan and Zhao, Na},
title = {NIR‐II Type I Photosensitizer for Efficient Cancer Therapy Through Synergistic Ferroptosis/Pyroptosis Induction and Mitophagy Inhibition},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202501346}
}
EUVIMED